MUMBAI, India, Aug. 10 -- Intellectual Property India has published a patent application (202648091776 A) filed by Board Of Regents, The University Of Texas System on July 29, 2026, for Prefusion-Stabilized Hmpv F Proteins.
Inventors include Mclellan, Jason; Hsieh, Ching-Lin; Rush, Scott; and Wang, Nianshuang.
The application for the patent was published on July 31, 2026, under issue no. 31/2026.
Abstract: ABSTRACT PREFUSION-STABILIZED HMPV F PROTEINS Provided herein are engineered hMPV F proteins. In some aspects, the engineered F proteins exhibit enhanced conformational stability and/or antigenicity. Methods are also provided for use of the engineered F proteins as diagnostics, in screening platforms, and/or in vaccine compositions.
Disclaimer: Curated by HT Syndication.
